1 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview
1.1 Product Overview and Scope of 23-Valent Pneumococcal Polysaccharide Vaccine
1.2 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
1.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
1.3.1 23-Valent Pneumococcal Polysaccharide Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 For Children (2-10)
1.3.3 For Person (10-64)
1.3.4 For The Old (?65)
1.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Estimates and Forecasts
1.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2016-2027
1.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2016-2027
1.4.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 23-Valent Pneumococcal Polysaccharide Vaccine Market Competition by Manufacturers
2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Sites, Area Served, Product Type
2.5 23-Valent Pneumococcal Polysaccharide Vaccine Market Competitive Situation and Trends
2.5.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest 23-Valent Pneumococcal Polysaccharide Vaccine Players Market Share by Revenue
2.5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 23-Valent Pneumococcal Polysaccharide Vaccine Retrospective Market Scenario by Region
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.3.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
3.3.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.4.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
3.4.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
3.5.2 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.6.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
3.6.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
3.7.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historic Market Analysis by Type
4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2016-2021)

5 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historic Market Analysis by Application
5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2016-2021)

6 Key Companies Profiled
6.1 MSD
6.1.1 MSD Corporation Information
6.1.2 MSD Description and Business Overview
6.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 MSD Product Portfolio
6.1.5 MSD Recent Developments/Updates
6.2 Sanofipasteur
6.2.1 Sanofipasteur Corporation Information
6.2.2 Sanofipasteur Description and Business Overview
6.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Sanofipasteur Product Portfolio
6.2.5 Sanofipasteur Recent Developments/Updates
6.3 CDIBP
6.3.1 CDIBP Corporation Information
6.3.2 CDIBP Description and Business Overview
6.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 CDIBP Product Portfolio
6.3.5 CDIBP Recent Developments/Updates

7 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Cost Analysis
7.1 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
7.4 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
8.3 23-Valent Pneumococcal Polysaccharide Vaccine Customers

9 23-Valent Pneumococcal Polysaccharide Vaccine Market Dynamics
9.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Trends
9.2 23-Valent Pneumococcal Polysaccharide Vaccine Growth Drivers
9.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
9.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints

10 Global Market Forecast
10.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2022-2027)
10.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of 23-Valent Pneumococcal Polysaccharide Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of 23-Valent Pneumococcal Polysaccharide Vaccine by Application (2022-2027)
10.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of 23-Valent Pneumococcal Polysaccharide Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of 23-Valent Pneumococcal Polysaccharide Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer